ACP said that the legislation should: Provide positive and stable payments to all physicians.

The first phase of the legislation would stabilize the payment rates under the current system while setting up the proceed to new payment versions. The next phase would then changeover away from fee-for-services and toward value-based models of payment with an revise incentive program. ACP said that the legislation should: Provide positive and stable payments to all physicians, with higher baseline updates for administration and evaluation services, for at least five years; Create an activity for physicians to qualify for graduated incentive-based payments during this time period of balance for participating in programs to boost quality and the effectiveness of care; Put greater focus on programs that could move from reporting on procedure measures at the average person physician level to applications that measure improvements in outcomes and patient experience carefully at the organizational and program level; Create a process to deem applications that would be eligible for graduated incentive structured payments; Create a clearer bridge between the draft bill's proposed fee-for-service competency-based incentive program and new payment versions, by creating incentives within the competency-based update program for doctors who are developing the competencies needed, of their practices and organizations, to successfully make the transition to new payment and delivery versions aligned with value; Create incentives for doctors to develop and participate in peer cohorts which have the ideal potential to improve outcomes, patient knowledge, and efficiency of the treatment provided, at both an organizational and individual level and of their own communities; Allow physicians in recognized PCMH procedures to be eligible for higher FFS obligations as early as next year; and Create an activity and timeline for HHS to evaluate, propose, and designate accepted fresh delivery and payment versions, with hardship exemptions.The ‘Various other’ Malaria: The deadliest malaria parasite is definitely Plasmodium falciparum, but its close cousin Plasmodium vivax is alive and thriving in Latin and Asia America. Experts discuss new methods to dealing with P. Vivax malaria, that may linger in the liver for a long time and cause multiple relapses. ‘A Vaccine for ‘Breakbone’ Fever?: Mosquito-borne dengue fever, categorised as ‘breakbone fever’ for the amazing pain it causes in the joints, is on the rise and has reemerged in Florida. The latest on a potential vaccine breakthrough and the challenges to rolling out immunizations for a disease associated with 100 million infections and 25,000 deaths each year.